GlaxoSmithKline abandoning iconic US HQ space in a shift inspired by the new normal
GlaxoSmithKline is radically downsizing — and the move has nothing to do with their head count.
Spurred by the pandemic-inspired reduction in the need for office space, the pharma giant is giving up its iconic facilities in Philadelphia and Research Triangle Park, and replacing the space with new digs that require only a fraction of what they once used.
Starting early next year, GlaxoSmithKline will be shrinking its office space in Philly by 75% as the pharma leaves their bespoke building in the Navy Yard — moving to the FMC Tower in Philly’s University City district. The company is also moving its offices from RTP to downtown Durham, NC by June, the company said — a downsize of close to 90%.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 128,800+ biopharma pros reading Endpoints daily — and it's free.